Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-25-003676
Filing Date
2025-01-27
Accepted
2025-01-27 06:10:21
Documents
13
Period of Report
2025-01-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 39948
  Complete submission text file 0001493152-25-003676.txt   218270

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE envb-20250124.xsd EX-101.SCH 3012
3 XBRL LABEL FILE envb-20250124_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE envb-20250124_pre.xml EX-101.PRE 22357
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4062
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38286 | Film No.: 25555663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)